Human MAP2K1-AVM ECs had consistent baseline MEK1 and ERK1/2 expression with controls; however, MAP2K1-AVM ECs produced 176% more active/ phosphorylated ERK1/2 than non-mutant ECs. Similarly, ECFCs engineered to overexpress mutant MAP2K1 demonstrated 433% more phosphorylated ERK1/2 expression than control ECFCs.
INTRODUCTION:
The field of tissue engineering has long held the promise of eventual production of a vascularized free flap in an "off-the-shelf " manner as a means of true dermal replacement. Our current state of dermal replacement utilizes an acellular dermal matrix that, while promising and effective, is severely limited by the condition of the bed onto which it is engrafted. A tissue engineered dermal replacement that includes an inherent vascular network would obviate this limitation and expand the clinical scope from the restraints of a well vascularized wound bed. We have previously demonstrated the ability to create an organized vascular conduit in vitro, and have even demonstrated the self-assembly of endothelial cells within a collagen matrix. Yet the task remains to anastomose a microsurgically relevant vascular channel with capillary-like vessels with the aim of developing a hierarchical vascular network able to perfuse a 3-dimensional space. Our previous experiments have demonstrated reliable endothelial cell sprouting from a monolayer under stimulation by a gradient of S1P, VEGF, and FGF. It is our hypothesis that the induction of such sprouts into a self-assembled endothelial cell network will anastomose to the network, thereby achieving hierarchical vascular organization that can be utilized in the ultimate production of tissue-engineered pre-vascularized free flaps.
METHODS:
Invasivity assays were created by injecting 3mg/ml Type 1 Collagen impregnated with 1 µM S1P into well plates. A monolayer of GFP-tagged Human Umbilical Vein Endothelial Cells (HUVECs) were topically seeded, covered with Endothelial Cell Media enhanced with VEGF and FGF, and cultured for 1, 3, and 5 Days. Assays were fixed and confocal imaged for invasion density per highpowered field (HPF) and average invasion depth. Self-assembled network assays were created by seeding a monolayer of GFP-tagged HUVECs as above, followed by injecting a second layer of Type 1 Collagen above the monolayer and coverage with growth factor enhanced media. Assays were fixed and confocal imaged for network formation and intra-capillary distance quantification. After optimization, combination cultures were created by layering a collagen base layer, a YFP-Tagged HUVEC network second layer, an S1P impregnated collagen third layer, and a topically seeded GFP-Tagged HUVEC monolayer. Combination cultures were cultured until similar time points and confocal imaged for analysis.
RESULTS:
Invasivity assays demonstrated robust sprouting with an average of 46.89 ± 2.54 by Day 1, 131.4 ± 10.34 by Day 3, and 321.3 ± 39.31 by Day 5 per 0.6 mm 2 . Selfassembled network assays demonstrated biologically appropriate inter-capillary distance less than 50mm by Day 5. Combination cultures demonstrated robust sprouting from both the network and monolayer and anastomosis as evidenced by YFP and GFP multi-fluorescent channels, however quantification of anastomoses are still in progress.
CONCLUSION:
In this project we have successfully demonstrated the ability of endothelial cells, under appropriate stimulation and conditions, to form a hierarchical vascular network that mimics that of normal human tissue in a way that is readily scalable and easily reproducible. Future iterations of this project will focus on a straight channel design and maintenance of the channel and network with flow. 
Refinements in Microcirculation of the

METHODS:
Fourteen hemi-abdominal flaps from the midline to mid-axillary line were harvested in fresh, nonfrozen human cadavers. Following perforator mapping, the venae comitantes of the largest DIEP perforator and the superficial inferior epigastric vein cannulated using a 27-gauge butterfly catheter. Flaps were evaluated with high resolution computed tomography (CT) following an injection of iodinated contrast (Omnipaque ®) to the DIEP venae comitantes and SIEV. The contrast agent was flushed out from the flap between injections. The dermis was subsequently removed with cautery at the subdermal dissection plane and flaps were re-imaged with CTA following injection in the DIEV perforator. Three-dimensional CT angiography of the venous territories allowed detailed assessment at each stage including perfusion areas, volume and pattern of perfusion.
RESULTS:
Average territory of the largest DIEV perforator was 180cm2 and extended to 47% of the hemiabdominal integument. Patterns of venous territory distribution from individual venous perforators were assessed in hemi-abdominal flaps of the anterior abdomen. The perfusion territory without the dermis was significantly reduced by a mean of 142cm2, P=0.01. Mean volume of perfusion was significantly reduced on average by 10cm3, P=0.01. A direct communication of the DIEV perforator with the superficial system was seen in 10/14 flaps (71%).
CONCLUSION:
Venous microcirculation plays a critical role in success of DIEP flap harvest. This study details patterns of venosomes of DIEV perforators, the comparison with the superficial system but appreciates the critical role of the preservation of the dermal integrity to preserve and optimize venous drainage of the flap by avoiding aggressive de-epithelialization.
